Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

2

Margin Of Safety %

Put/Call OI Ratio

0.29

EPS Next Q Diff

-0.66

EPS Last/This Y

1.99

EPS This/Next Y

1.95

Price

15.16

Target Price

11

Analyst Recom

4.33

Performance Q

38.07

Relative Volume

0.77

Beta

0.85

Ticker: AMRN




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04AMRN16.730.304.959860
2025-07-07AMRN16.670.320.069984
2025-07-08AMRN16.830.310.0610084
2025-07-09AMRN17.370.310.1010136
2025-07-10AMRN17.240.311.1610149
2025-07-11AMRN16.950.322.2910157
2025-07-14AMRN160.350.2710605
2025-07-15AMRN15.780.350.3910763
2025-07-16AMRN15.830.360.8510801
2025-07-17AMRN15.80.380.4811005
2025-07-18AMRN15.830.381.4111071
2025-07-21AMRN15.570.260.448579
2025-07-22AMRN15.330.270.288732
2025-07-23AMRN15.60.270.118813
2025-07-24AMRN15.520.275.008865
2025-07-25AMRN15.450.270.148871
2025-07-28AMRN150.270.558876
2025-07-29AMRN14.640.290.289399
2025-07-30AMRN14.960.290.199464
2025-07-31AMRN14.450.290.159627
2025-08-01AMRN15.160.290.309643
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04AMRN16.73-405.0- -2.01
2025-07-07AMRN16.60-405.0- -2.01
2025-07-08AMRN16.83-405.0- -2.01
2025-07-09AMRN17.33-405.0- -2.01
2025-07-10AMRN17.32-405.0- -2.01
2025-07-11AMRN16.93-405.0- -2.01
2025-07-14AMRN16.10-405.0- -2.01
2025-07-15AMRN15.78-405.0- -2.01
2025-07-16AMRN15.81-405.0- -2.01
2025-07-17AMRN15.79-405.0- -2.01
2025-07-18AMRN15.85-405.0- -2.01
2025-07-21AMRN15.57-405.0- -2.01
2025-07-22AMRN15.29-405.0- -2.01
2025-07-23AMRN15.59-405.0- -2.01
2025-07-24AMRN15.50-405.0- -2.01
2025-07-25AMRN15.39-405.0- -2.01
2025-07-28AMRN14.94-405.0- -2.01
2025-07-29AMRN14.65-405.0- -2.01
2025-07-30AMRN14.97-405.0- -2.01
2025-07-31AMRN14.52-405.0- -2.01
2025-08-01AMRN15.1630.0- -2.01
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04AMRN0.001.372.08
2025-07-07AMRN0.001.372.08
2025-07-08AMRN0.001.372.08
2025-07-09AMRN0.001.372.08
2025-07-10AMRN0.001.372.08
2025-07-11AMRN0.001.372.17
2025-07-14AMRN0.000.672.17
2025-07-15AMRN0.000.672.17
2025-07-16AMRN0.000.672.17
2025-07-17AMRN0.000.672.17
2025-07-18AMRN0.000.672.17
2025-07-21AMRN0.000.472.17
2025-07-22AMRN0.000.472.17
2025-07-23AMRN0.000.472.17
2025-07-24AMRN0.000.472.17
2025-07-25AMRN0.000.472.01
2025-07-28AMRN0.00-1.102.01
2025-07-29AMRN0.00-1.102.01
2025-07-30AMRN0.00-1.102.01
2025-07-31AMRN0.00-1.102.01
2025-08-01AMRN0.00-1.102.00
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.03

Avg. EPS Est. Current Quarter

-0.7

Avg. EPS Est. Next Quarter

-0.69

Insider Transactions

Institutional Transactions

-1.1

Beta

0.85

Average Sales Estimate Current Quarter

57

Average Sales Estimate Next Quarter

60

Fair Value

Quality Score

34

Growth Score

24

Sentiment Score

61

Actual DrawDown %

91.8

Max Drawdown 5-Year %

-95.5

Target Price

11

P/E

Forward P/E

PEG

P/S

1.43

P/B

0.68

P/Free Cash Flow

EPS

-5.03

Average EPS Est. Cur. Y​

-2.01

EPS Next Y. (Est.)

-0.06

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-47.05

Relative Volume

0.77

Return on Equity vs Sector %

-46

Return on Equity vs Industry %

-54.3

EPS 1 7Days Diff

1.2

EPS 1 30Days Diff

1.19

EBIT Estimation

Amarin Corporation plc
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 275
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin 2, Ireland.
stock quote shares AMRN – Amarin Corp ADR Stock Price stock today
news today AMRN – Amarin Corp ADR stock forecast ,stock prediction 2023 2024 2025
marketwatch AMRN – Amarin Corp ADR yahoo finance google finance
stock history AMRN – Amarin Corp ADR invest stock market
stock prices AMRN premarket after hours
ticker AMRN fair value insiders trading